These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20001861)

  • 1. Involvement of annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study.
    Zhu F; Wang Y; Zeng S; Fu X; Wang L; Cao J
    OMICS; 2009 Dec; 13(6):467-76. PubMed ID: 20001861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of a K562 multidrug-resistant cell line and study on proteins with altered expression].
    Wang Y; Cao J; Zeng S
    Shi Yan Sheng Wu Xue Bao; 2003 Oct; 36(5):342-6. PubMed ID: 14724945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.
    Wang L; Meng Q; Wang C; Liu Q; Peng J; Huo X; Sun H; Ma X; Liu K
    J Nat Prod; 2013 May; 76(5):909-14. PubMed ID: 23621869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity.
    Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
    Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance.
    Li RJ; Zhang GS; Chen YH; Zhu JF; Lu QJ; Gong FJ; Kuang WY
    Ann Oncol; 2010 Jul; 21(7):1506-1514. PubMed ID: 20038517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of high expression of HSP27 to multidrug resistance of leukemia cell line K562/VCR].
    Zhang ZX; Wen FQ; Liu ZP; Cheng YD
    Ai Zheng; 2008 Apr; 27(4):348-53. PubMed ID: 18423118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Up-regulation of Stathmin and CrkL protein expressions in adriamycin-resistant leukemia cell line K562/A02].
    Xu JP; Hu JD; Lin MH; Li J; Liu TB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1383-7. PubMed ID: 22169288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
    Li J; Xu LZ; Yao JJ; Guo WJ; Xia P; Chen Y
    Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.
    Zhang F; Zhang L; Zhang B; Wei X; Yang Y; Qi RZ; Ying G; Zhang N; Niu R
    J Proteome Res; 2009 Nov; 8(11):5041-7. PubMed ID: 19764771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells.
    Shen SH; Gu LJ; Liu PQ; Ye X; Chang WS; Li BS
    Chin Med J (Engl); 2008 Mar; 121(5):463-8. PubMed ID: 18364123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
    Liu Y; Liu H; Han B; Zhang JT
    Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro anti-leukemia activity of dual PI3K/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60/ADR and K562/A02 cells.
    Zhang L; Wang Z; Khishignyam T; Chen T; Zhou C; Zhang Z; Jin M; Wang R; Qiu Y; Kong D
    Biomed Pharmacother; 2018 Jul; 103():1069-1078. PubMed ID: 29710665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Annexin A1 interacting proteins in chronic myeloid leukemia KCL22 cells.
    Colavita I; Esposito N; Quintarelli C; Nigro E; Pane F; Ruoppolo M; Salvatore F
    Proteomics; 2013 Aug; 13(16):2414-8. PubMed ID: 23754495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proteomic investigation into adriamycin chemo-resistance of human leukemia K562 cells.
    Peng X; Gong F; Xie G; Zhao Y; Tang M; Yu L; Tong A
    Mol Cell Biochem; 2011 May; 351(1-2):233-41. PubMed ID: 21243406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical involvement of the α(1,2)-fucosyltransferase in multidrug resistance of human chronic myeloid leukemia.
    Che Y; Ren X; Xu L; Ding X; Zhang X; Sun X
    Oncol Rep; 2016 May; 35(5):3025-33. PubMed ID: 26986216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
    Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
    Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin enhances adriamycin cytotoxicity through induction of apoptosis and regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase/c-Jun N-terminal kinase signaling in multidrug-resistant leukemia K562 cells.
    Chen FY; Cao LF; Wan HX; Zhang MY; Cai JY; Shen LJ; Zhong JH; Zhong H
    Mol Med Rep; 2015 Jan; 11(1):341-8. PubMed ID: 25339540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin-resistant cell line.
    Zhou H; Zhang Z; Liu C; Jin C; Zhang J; Miao X; Jia L
    IUBMB Life; 2012 Nov; 64(11):889-900. PubMed ID: 23024026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis.
    Wang W; Niu S; Qiao L; Wei F; Yin J; Wang S; Ouyang Y; Chen D
    Biomed Res Int; 2019; 2019():8727935. PubMed ID: 30886864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.